Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Comparability of Bococizumab Manufacturing Sites and Delivery Devices in Healthy Adults
NCT02458209Phase 1Completed
- Sponsor
- Pfizer
- Start
- May 2015
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bococizumab in hypercholesterolemia (3 arms), sponsored by Pfizer. Primary endpoints: Maximum Observed Plasma Concentration and Area Under the Curve from Time Zero to Infinity. Started May 2015; status: completed.
02
Drugs
bococizumab
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02458209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02458209.